Atlas Trials

Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer

Clinical trial NCT05377047 · RECRUITING

Trial details

NCT number
NCT05377047
Sponsor
Vastra Gotaland Region
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer Stage IVOligometastatic Disease
Start date
2022-09-19
Primary completion
2025-12-31
Enrollment
345

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.